185 filings
Page 4 of 10
8-K
22swx9cbmroucrtvd
9 Aug 19
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
9:02am
8-K
47zaly
7 Aug 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
8:00am
8-K
mchwl7nc70o 6a
29 Jul 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million
8:30am
8-K
k0k2lgt iype6rzpbaq
25 Jul 19
Departure of Directors or Certain Officers
4:30pm
8-K
7ngdslusab
15 Jul 19
NovaBay Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
pcxiniq0vb w9yg1
1 Jul 19
Other Events
8:32am
8-K
5t9 qz9mg0idwed5y5b
26 Jun 19
Entry into a Material Definitive Agreement
4:31pm
8-K
a2gepu0o
19 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
4e3sugrp
17 Jun 19
NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO
8:31am
8-K
px993w2 8vwv
3 Jun 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
xojv0q6dmcl xvqy2
21 May 19
NovaBay Pharmaceuticals Receives NYSE American Communication
4:50pm
8-K
7ocpy0xzlrbwwhjpwnb
13 May 19
NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results
4:30pm
8-K
pg7enp6mcl e5rd3dds6
3 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
wzoaqlu
15 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
12mxrlt
1 Apr 19
NovaBay Pharmaceuticals Announces Investments of $5 Million to Support U.S. Avenova Commercialization Strategy
9:17am
8-K
lxvff4kppgyi3q9i0
28 Mar 19
Entry into a Material Definitive Agreement
8:45am
8-K
gftggqthbt vfdeixz
12 Mar 19
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
4:30pm
8-K
xpu63deokl4v5w14ktej
11 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
05s2uzx4r9i wwtp91
1 Mar 19
Entry into a Material Definitive Agreement
12:00am
8-K
6k776ye6
11 Oct 18
Departure of Directors or Certain Officers
4:30pm